SEC Form 4 · accession 0001057265-17-000001
AMERICAN BIO MEDICA CORP · ABMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John J Moroney
10% Owner
Period of report
May 8, 2017
Accepted (ET)
May 17, 2017 · 1:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896747
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | May 8, 2017 | J | 245,545 | $0.00 | A | 1,887,838 | I | By: Landmark Pegasus, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transfer agent was instructed to issue shares on May 8th, 2017. Transfer agent confirmed transaction was completed on May 15th, 2017.
- F2Landmark Pegasus, Inc. acquired the securities being reported as payment (from the issuer) of a fee pursuant to a Financial Advisor Agreement with the Issuer. The total amount of securities issued was 454,545 of which only 254,545 were issued to Landmark Pegasus, Inc. The remaining 200,000 common stock were issued to another principal of Landmark Pegasus, Inc who does not control the Landmark Pegasus, Inc shares and who is not a 10% owner or affiliate of the Company.
Remarks
In addition to the common shares indicated, the reporting person shares beneficial ownership of a presently exercisable warrant to acquire 200,000 shares of common stock held by F&M Investment Partnership. In total, the reporting person is the beneficial owner of 4,096,171 shares of common stock of the Issuer.